Using a specific anti-vascular endothelial growth factor (VEGF) drug in patients with moderately severe to severe nonproliferative diabetic retinopathy (NPDR) can result i
Editor's note: Ophthalmology Times is pleased to recognize Xuejing (Jing) Chen, MD, vitreoretinal fellow, Tufts Medical Center, Ophthalmic Consultants of Boston, as the fifth-place honoree of the inaugural Op
Advancing pregnancy induces obvious physical changes for women over time.
In 1997, a book published by neurologist Oliver Sacks, MD, “The Island of the Colorblind,” revealed an unusual trait in the inhabitants of the small Micronesian island of Pingelap—they were born completely colorblind.
Light induced visual-response (LIV)—the use of light to stimulate electrical responses from cells within the eye—has recently emerged as a better way to describe visual electrophysiology testing.
As an objective measure of global retinal function, flicker electroretinography (ERG) testing, also referred to as light-induced vision response, has several potential applications in ophthalmology.
With all the technological and medical advances for the treatment of diabetic eye diseases, retinal specialists still have an ongoing therapy issue because patients require continual and constant monitoring and maintenance, said Rishi P.
Micoaneurysm turnover in the early stages of diabetic retinopathy predicts how much the disease will progress, according to researchers.